相似文献
1
Evaluation of the C6 peptide enzyme-linked immunosorbent assay for individuals vaccinated with the recombinant OspA vaccine.
J Clin Microbiol. 2002 Jul;40(7):2591-3. doi: 10.1128/JCM.40.7.2591-2593.2002.
2
Recombinant assay for serodiagnosis of Lyme disease regardless of OspA vaccination status.
J Clin Microbiol. 2002 Jan;40(1):193-7. doi: 10.1128/JCM.40.1.193-197.2002.
3
Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease.
Clin Vaccine Immunol. 2008 Dec;15(12):1796-804. doi: 10.1128/CVI.00195-08. Epub 2008 Oct 22.
4
Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
J Mol Biol. 2005 Jul 8;350(2):290-9. doi: 10.1016/j.jmb.2005.04.066.
5
Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE.
J Clin Microbiol. 1999 Dec;37(12):3990-6. doi: 10.1128/JCM.37.12.3990-3996.1999.
6
A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.
Vet Immunol Immunopathol. 2011 Apr 15;140(3-4):190-8. doi: 10.1016/j.vetimm.2010.12.003. Epub 2010 Dec 10.
7
Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
Vaccine. 2017 May 31;35(24):3178-3185. doi: 10.1016/j.vaccine.2017.04.079. Epub 2017 May 4.
8
Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi.
Clin Diagn Lab Immunol. 2004 May;11(3):458-62. doi: 10.1128/CDLI.11.3.458-462.2004.
9
Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
Vaccine. 2006 Mar 10;24(11):1949-57. doi: 10.1016/j.vaccine.2005.10.044. Epub 2005 Nov 4.
10
Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.
Clin Diagn Lab Immunol. 2001 Jan;8(1):79-84. doi: 10.1128/CDLI.8.1.79-84.2001.
引用本文的文献
1
Canine and human infection with Borrelia burgdorferi in the New York City metropolitan area.
Parasit Vectors. 2018 Mar 20;11(1):187. doi: 10.1186/s13071-018-2774-z.
2
Laboratory diagnosis of Lyme disease: advances and challenges.
Infect Dis Clin North Am. 2015 Jun;29(2):295-307. doi: 10.1016/j.idc.2015.02.005.
3
Occurrence of Dirofilaria immitis and tick-borne infections caused by Anaplasma phagocytophilum, Borrelia burgdorferi sensu lato and Ehrlichia canis in domestic dogs in France: results of a countrywide serologic survey.
Parasitol Res. 2009 Aug;105 Suppl 1:S101-14. doi: 10.1007/s00436-009-1501-2.
4
Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease.
Clin Vaccine Immunol. 2008 Dec;15(12):1796-804. doi: 10.1128/CVI.00195-08. Epub 2008 Oct 22.
5
Sensitivity and specificity of a commercial C6 peptide enzyme immuno assay in diagnosis of acute Lyme neuroborreliosis.
Eur J Clin Microbiol Infect Dis. 2007 Sep;26(9):675-7. doi: 10.1007/s10096-007-0336-y.
6
A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis.
Clin Diagn Lab Immunol. 2005 Sep;12(9):1069-74. doi: 10.1128/CDLI.12.9.1069-1074.2005.
7
Lyme disease.
Curr Neurol Neurosci Rep. 2002 Nov;2(6):479-87. doi: 10.1007/s11910-002-0033-2.
本文引用的文献
1
Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.
Clin Diagn Lab Immunol. 2001 Jan;8(1):79-84. doi: 10.1128/CDLI.8.1.79-84.2001.
2
Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay.
J Clin Microbiol. 2000 Nov;38(11):4160-6. doi: 10.1128/JCM.38.11.4160-4166.2000.
3
Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL.
J Infect Dis. 2000 Nov;182(5):1455-62. doi: 10.1086/315862. Epub 2000 Oct 9.
4
Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
Clin Infect Dis. 2000 Jul;31(1):42-7. doi: 10.1086/313920. Epub 2000 Jul 17.
5
Evaluation of whole-cell and OspC enzyme-linked immunosorbent assays for discrimination of early lyme borreliosis from OspA vaccination.
J Clin Microbiol. 2000 Jan;38(1):313-7. doi: 10.1128/JCM.38.1.313-317.2000.
6
Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE.
J Clin Microbiol. 1999 Dec;37(12):3990-6. doi: 10.1128/JCM.37.12.3990-3996.1999.
7
An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi.
J Immunol. 1999 Nov 15;163(10):5566-73.
8
Effects of OspA vaccination on Lyme disease serologic testing.
J Clin Microbiol. 1999 Nov;37(11):3718-21. doi: 10.1128/JCM.37.11.3718-3721.1999.
9
Lyme borreliosis.
Lancet. 1998 Aug 15;352(9127):557-65. doi: 10.1016/S0140-6736(98)01146-5.
10
Clinical and immunological assessment of a candidate Lyme disease vaccine in healthy adults: antibody persistence and effect of a booster dose at month 12.
Vaccine. 1998 Oct;16(17):1688-92. doi: 10.1016/s0264-410x(98)00052-8.
Zotero 插件